ArticleBMJ case reports2026
Congenital cervical neuroblastoma presenting with spontaneous tumour lysis syndrome and severe neonatal airway compromise.
Article in BMJ case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A term male neonate was delivered at 37 weeks and 3 days gestation in April 2025 via urgent caesarean section due to non-reassuring fetal heart tones. At birth, an unanticipated large right-sided cervical mass caused immediate respiratory distress, necessitating emergent endotracheal intubation. Within the first 24 hours of life, the infant developed spontaneous tumour lysis syndrome (TLS) with severe electrolyte derangements, metabolic acidosis and profound cardiac dysfunction, a phenomenon that has been rarely described in neonates with congenital malignancies. Imaging revealed a cervical mass with mediastinal extension and hepatic metastases. Core biopsy confirmed International Neuroblastoma Risk Group stage MS neuroblastoma, corresponding to historic International Neuroblastoma Staging System stage 4S, MYCN non-amplified, with favourable histology. Multidisciplinary management included airway stabilisation, TLS-directed therapy and early chemotherapy, resulting in rapid metabolic stabilisation and tumour regression. The infant was discharged on day 44 with improving respiratory status and ongoing outpatient oncology follow-up. This case emphasises the need for rapid recognition of TLS in congenital malignancies and coordinated airway and oncological care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.